Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Cancer Research and Clinical Oncology

Topics

Medicine

Cancer Oncology

Immunology

Internal Medicine

Hematology

Show all topics

DOI

10.1007/s00432-024-05812-4

License

CC-BY

Other Formats

PDF